MedPath

Study of effects of nasal dexmedetomidine and midazolam before operation in childre

Phase 3
Conditions
Health Condition 1: O- Medical and SurgicalHealth Condition 2: 8- Other Procedures
Registration Number
CTRI/2024/03/063804
Lead Sponsor
Pt BD Sharma University of Health Sciences Rohtak
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children belonging to either sex age between 2 t0 8 year with ASA physical status 1 and 11 scheduled to undergo various elective surgical procedures

Exclusion Criteria

1 children with systemic illness

2 parent refusal

3 known allergic to midazolam and dexmedetomidine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
comparative study between intranasal atomized midazolam and dexmedetomidineTimepoint: outcome will be accessed after 30 minute of drug administration
Secondary Outcome Measures
NameTimeMethod
1 sedation score <br/ ><br>2 parent separation <br/ ><br>3 mass acceptanceTimepoint: accessed after 30 minute of drug administration
© Copyright 2025. All Rights Reserved by MedPath